U.S. Portable Hemodialysis Machines Market

Market Outlook

By 2035, the U.S. Portable Hemodialysis Machines Market is expected to reach approximately USD 1.99 billion, expanding at a CAGR of 13.10% during the forecast period 2026–2035. The market is estimated at USD 0.58 billion in 2025, following expansion from approximately USD 0.33 billion in 2021, USD 0.38 billion in 2022, USD 0.44 billion in 2023, and USD 0.51 billion in 2024. Values in this report are expressed in USD billions.

The U.S. portable hemodialysis machines industry sits at the intersection of three structural shifts in kidney care: migration of selected dialysis treatment from clinics to homes, development of simpler and smaller hemodialysis platforms, and growing economic pressure to reduce dependence on traditional high-infrastructure dialysis delivery. More than 35 million U.S. adults are estimated to have chronic kidney disease, while the national end-stage kidney disease population exceeds 900,000 people and approximately 589,000 patients were receiving hemodialysis in 2023. This establishes a clinically substantial addressable population even though portable and home hemodialysis currently represent only a fraction of total hemodialysis treatment.

Portable hemodialysis is fundamentally different from conventional in-center dialysis equipment. The commercial value proposition is not simply a smaller machine. Successful systems must reduce water-treatment complexity, simplify treatment setup, support non-specialist users, control disposable costs, transmit treatment data, provide reliable alarm management, and operate within home, post-acute, rural, or decentralized care environments. Portability therefore has to be evaluated as a combination of machine footprint, weight, plumbing requirements, electrical requirements, consumable architecture, transportation feasibility, user-interface design, and care-team workflow.

The competitive environment is also moving beyond a historically concentrated category. Fresenius Medical Care’s NxStage platform remains the most established portable home hemodialysis ecosystem in the United States. Outset Medical’s Tablo has established a compact platform spanning hospital and home applications. Quanta has obtained U.S. authorization for home use of its compact SC+ system, while Diality is developing the home-use pathway for its Moda-flx platform after obtaining clearance for professional care environments. These developments create a substantially more competitive technology cycle for the 2026–2035 period.

For purposes of this market analysis, portable hemodialysis machines include compact and transportable hemodialysis platforms specifically designed to reduce infrastructure requirements or enable treatment outside conventional dialysis stations. The market model includes machine systems and machine-dependent treatment technology such as proprietary cartridges, integrated dialysate preparation components, machine-specific fluid-management consumables, software, and connectivity that directly support system utilization. It excludes dialysis service revenue, conventional fixed in-center hemodialysis equipment, peritoneal dialysis cyclers, independent dialyzers not linked to a portable platform, pharmaceuticals, and kidney transplantation.

Introduction

According to the U.S. Portable Hemodialysis Machines Market Report, demand is being shaped by an unusually complex combination of clinical need, patient lifestyle requirements, dialysis-provider economics, reimbursement policy, training infrastructure, device usability, and regulatory expectations.

The underlying disease burden provides a durable foundation. Chronic kidney disease affects more than one in seven U.S. adults, and prevalence rises sharply with age. Approximately one-third of adults aged 65 years or older have CKD. Diabetes and hypertension remain the two most important upstream conditions contributing to kidney failure, making the dialysis market closely connected with broader U.S. trends in obesity, diabetes, cardiovascular disease, and aging.

In 2023, approximately 933,000 people were living with end-stage kidney disease in the United States. More than 675,000 were receiving dialysis, and close to 589,000 were receiving hemodialysis. This means portable hemodialysis technology does not require major expansion of the total kidney-failure population to produce substantial commercial growth. Relatively small shifts in the percentage of appropriate patients moving from conventional clinic-based HD into home, self-care, skilled nursing, or decentralized treatment models could create meaningful incremental equipment demand.

One of the strongest market signals is the expanding installed base of dedicated home hemodialysis technology. By 2025, more than 15,300 U.S. patients were reportedly using Fresenius Medical Care’s NxStage systems for home hemodialysis, up from more than 14,500 in 2024. The company has also reported tens of millions of cumulative home treatments using NxStage products. This installed base demonstrates that portable HHD has progressed well beyond pilot-stage adoption and has established operational infrastructure involving training centers, supply distribution, clinical support, remote monitoring, travel prescriptions, and recurring consumable logistics.

The commercial opportunity, however, remains substantially underpenetrated relative to total hemodialysis volume. The largest structural barrier is not machine efficacy alone. Patient selection, vascular access, home environment, health literacy, caregiver availability, storage space, training requirements, emergency preparedness, supply delivery, clinician confidence, and the ability to troubleshoot therapy without immediate staff intervention all influence adoption.

Consequently, the next decade is likely to reward platforms that reduce the operational burden surrounding dialysis rather than simply improving clearance performance. A machine that requires less home modification, guides users through setup, automates fluid management, reduces error opportunities, supports remote technical assistance, and feeds treatment information back to clinicians can generate more economic value than a technically advanced system requiring substantial nursing support.

Hospital and dialysis-provider procurement behavior will increasingly evaluate portable machines through total treatment economics. Buyers will examine training time, patient retention, machine utilization, consumable cost per treatment, field-service requirements, emergency failure rates, supply-chain reliability, water use, staffing implications, hospitalization risk, and the ability to support multiple care environments.

The category therefore represents a transition from traditional dialysis equipment toward distributed kidney-care infrastructure.

Key Market Drivers: What’s Fueling the U.S. Portable Hemodialysis Machines Market Boom?

The most fundamental market driver is the scale of U.S. kidney disease. Approximately 35.5 million adults have CKD, while hundreds of thousands require maintenance dialysis. Diabetes accounts for approximately 45% of prevalent hemodialysis patients’ underlying kidney-failure cause, while hypertension accounts for roughly another 31%. These conditions are highly prevalent across the U.S. and ensure that kidney replacement therapy will remain a major healthcare requirement throughout the forecast period.

The second major driver is the persistent interest in expanding home dialysis. Home treatment gives appropriately selected patients greater scheduling flexibility and reduces repeated travel to dialysis centers. Traditional in-center hemodialysis generally requires three scheduled facility visits per week, creating transportation, employment, caregiver, and quality-of-life burdens. Portable HHD systems can enable more individualized schedules, including more frequent daytime dialysis and selected nocturnal treatment protocols.

The third driver is technological simplification. Earlier home hemodialysis programs often depended on equipment derived from conventional clinic machines, extensive plumbing modifications, complex water-treatment infrastructure, and significant patient training. Newer systems are increasingly designed around cartridge-based fluid pathways, touchscreen interfaces, automated setup processes, integrated water-treatment options, graphical troubleshooting, cloud connectivity, and reduced physical footprints.

Portability itself has become an increasingly meaningful differentiator. NxStage systems, for example, are designed around a compact cycler that can operate with premixed dialysate bags, enabling patients to maintain treatment away from their primary residence when clinically and logistically appropriate. Such flexibility can materially influence patient willingness to accept HHD because treatment no longer has to create a fixed geographic dependency.

The fourth driver is dialysis workforce pressure. Conventional dialysis requires significant technician and nursing infrastructure. While home hemodialysis does not eliminate clinical oversight, it changes where labor is deployed. Nurses are increasingly used for assessment, training, care planning, remote management, retraining, and exception handling rather than physically administering every routine treatment. For dialysis organizations facing workforce constraints, systems that can safely shift suitable patients toward self-care can become strategically valuable.

The fifth driver is reimbursement alignment with home and self-dialysis infrastructure. Medicare’s ESRD payment structure includes mechanisms supporting home and self-dialysis training. The CY 2026 ESRD PPS base rate increased to USD 281.71 per treatment, and the bundled structure continues to recognize applicable training-related adjustments. CMS also expanded home dialysis payment opportunities for qualifying acute kidney injury treatment beginning in 2025, potentially broadening experience with home renal replacement therapy beyond the traditional chronic ESRD population.

The early termination of the ESRD Treatment Choices model does introduce an important policy nuance. ETC was designed to accelerate home dialysis and transplantation but was discontinued after CMS concluded that expected quality and expenditure outcomes were not being achieved. The termination reduces one specific policy incentive, but it does not reverse the broader clinical and economic rationale for home dialysis. Instead, manufacturers will increasingly need to prove their value through provider economics, patient retention, clinical performance, workflow reduction, and scalable implementation rather than relying on policy-driven modality targets.

The sixth driver is the expansion of alternative care sites. Skilled nursing facilities, rehabilitation centers, long-term care organizations, rural providers, hospitals without full dialysis departments, and selected decentralized treatment sites increasingly need systems that are easier to deploy than conventional water-room-dependent dialysis equipment. Portable platforms can address these environments by reducing infrastructure requirements and allowing kidney care to follow the patient.

The seventh driver is connected care. Home dialysis programs generate substantial operational data relating to treatment completion, alarms, pressures, ultrafiltration, treatment duration, adherence, and equipment performance. Remote connectivity enables clinicians to review treatments without relying entirely on manually recorded patient logs. Over the forecast period, software integration will increasingly become part of machine procurement rather than an optional add-on.

Innovation in Focus: How Manufacturers Are Raising the Bar?

The principal innovation cycle in portable hemodialysis is shifting from machine miniaturization toward complete workflow redesign.

Machine footprint remains important, particularly for apartments, elderly households, and patients who travel. However, reducing size without simplifying setup does not solve the primary adoption barrier. Manufacturers are therefore placing greater emphasis on guided interfaces, automated priming, cartridge-based circuits, simplified dialysate preparation, integrated water purification, alarm resolution, and automated treatment documentation.

Fresenius Medical Care’s NxStage VersiHD with GuideMe Software illustrates the direction of the market. The platform uses graphical, step-by-step software guidance intended to make setup and troubleshooting easier for patients, caregivers, and nurses. This type of software-driven usability engineering is strategically important because training burden directly affects the economics of home dialysis programs.

Fluid-management architecture represents another area of differentiation. Bagged dialysate enables treatment without continuous reliance on a dedicated water-treatment system and can facilitate travel or emergency continuity. Integrated water purification, by contrast, reduces the recurring handling and storage burden created by large volumes of premixed fluid. The winning architecture will vary according to treatment prescription, patient lifestyle, residence type, provider logistics, and treatment frequency.

Outset Medical’s Tablo represents a different design philosophy. The system integrates water purification and on-demand dialysate generation into a compact mobile platform and has been cleared for both professional environments and home use. Its strategic value lies in offering providers a standardized dialysis platform that can potentially operate across multiple care settings rather than maintaining completely separate machine fleets.

Quanta’s SC+ introduces further competition into this category. Its U.S. home-use clearance creates an additional commercial platform designed around compact architecture and a user interface intended to support home therapy. More competitors increase pressure on established companies to improve training efficiency, service models, consumable economics, and interoperability.

Diality’s Moda-flx adds another strategic dimension. The platform obtained FDA clearance for professional care environments and incorporates integrated reverse-osmosis water filtration. Diality is separately evaluating home use through clinical development. If additional systems successfully obtain home indications, procurement teams will gain greater negotiating leverage and may begin evaluating machines through measurable economic scorecards rather than brand familiarity alone.

Remote technical support will also become a competitive differentiator. Home users cannot depend on an on-site biomedical engineer when a machine alarm occurs. Vendors that maintain strong first-call resolution, virtual support, predictive maintenance, replacement logistics, and clinician-facing dashboards can reduce missed treatments and protect patient confidence.

Artificial intelligence is likely to enter the category cautiously. Autonomous clinical decision-making will remain constrained by regulatory and safety considerations, but AI-supported troubleshooting, predictive service, anomaly detection, user guidance, training personalization, and clinician triage could reduce operational friction.

The longer-term innovation frontier includes sorbent technologies, dialysate regeneration, substantially lower water consumption, highly portable systems, wearable artificial-kidney concepts, and compact technologies capable of moving closer to continuous renal replacement. Commercialization will depend on reliability, vascular access safety, battery and fluid requirements, clearance performance, manufacturing cost, and patient usability.

Segmentation Insights

The U.S. Portable Hemodialysis Machines Market is segmented on the basis of product category, application, end user, technology type, and region.

By Product Category

Portable Home Hemodialysis Cyclers

Portable home hemodialysis cyclers represent the most strategically important product category because they directly address the mobility and self-care proposition underlying the market. These machines are designed to occupy considerably less space than conventional in-center HD stations and support treatment within residential environments.

The category is led by established NxStage platforms, where machine portability is combined with cartridge-based treatment architecture and flexible dialysate options. Growth is expected to remain strong as providers expand HHD programs and as patient-facing software lowers the learning burden.

Compact Integrated Hemodialysis Systems

Compact integrated systems combine dialysis delivery with components such as water purification or on-demand dialysate generation. These platforms are less travel-oriented than the smallest portable cyclers but can be highly attractive for homes, hospitals, post-acute facilities, and decentralized treatment sites because they reduce external infrastructure.

This category should capture increasing market value because providers can use the same platform across multiple settings and potentially improve fleet standardization, staff familiarity, service efficiency, and capital utilization.

Cartridge-Based Low-Infrastructure Systems

Cartridge-based systems use proprietary disposable fluid pathways and treatment sets designed to simplify preparation, reduce cleaning requirements, and make treatment more reproducible. Their business model is particularly attractive to manufacturers because each installed machine creates recurring consumable revenue.

For buyers, the critical issue is total cost per treatment. A low-cost machine can become economically unattractive if disposable expenses are high, while a higher-priced platform can create better economics if it materially reduces nursing time, maintenance, infrastructure, and treatment failures.

Next-Generation and Emerging Portable Platforms

Emerging systems include new compact home HD platforms, next-generation dialysate management technologies, sorbent-based concepts, and systems being developed for substantially greater portability. This remains a smaller revenue category in 2025 but could become one of the fastest-growing subsegments after 2028 as additional devices obtain regulatory clearance.

By Application

Home Hemodialysis

Home hemodialysis is the dominant long-term application and the primary growth engine for portable machine demand. The application includes patients performing daytime, frequent, or physician-prescribed home treatment after completing appropriate clinical and operational training.

The value proposition is strongest for motivated patients who seek greater control over treatment timing, employment, family responsibilities, and travel. Continued expansion will depend on reducing training attrition and ensuring that patients can remain successfully on HHD after initiation.

Short Daily Hemodialysis

Short daily hemodialysis typically involves more frequent treatment than conventional thrice-weekly dialysis. Portable systems are well suited to this application because treatment schedules can be individualized without requiring patients to visit a facility every time.

The segment generates attractive recurring consumable demand because increasing treatment frequency increases the utilization of cartridges, blood tubing, dialysate, and machine-specific disposables.

Nocturnal Home Hemodialysis

Nocturnal HHD allows selected patients to receive longer-duration dialysis during sleep. Longer and potentially more frequent dialysis can improve solute and fluid management for appropriate patients, but overnight treatment requires particularly robust safety architecture.

Growth will depend on venous needle dislodgement safeguards, alarm reliability, caregiver requirements, remote monitoring, patient confidence, and physician familiarity.

Acute, Post-Acute, and Decentralized Hemodialysis

Portable and compact systems are increasingly relevant outside the traditional home. Skilled nursing facilities, rehabilitation centers, community hospitals, emergency preparedness programs, and decentralized care environments can use portable technology where installing a conventional dialysis water room would be operationally difficult.

This application is expected to become an important secondary growth engine because the economic value extends beyond patient convenience into facility infrastructure avoidance.

By End User

Home Dialysis Patients

Home dialysis patients represent the most important user group. They prioritize machine reliability, simplified setup, manageable storage requirements, intuitive alarms, portability, treatment flexibility, and access to technical support.

Manufacturers that design around the real residential environment rather than the dialysis clinic will have a competitive advantage. Apartments, limited storage, caregiver schedules, household plumbing, internet connectivity, and transportation all affect the suitability of a machine.

Dialysis Providers

Large dialysis organizations and independent dialysis providers control much of the pathway through which patients enter HHD. Their purchasing criteria emphasize training efficiency, patient retention, consumable economics, clinical documentation, inventory management, field service, payer coverage, and interoperability.

Fresenius Kidney Care, DaVita, U.S. Renal Care, Dialysis Clinic Inc., Innovative Renal Care, and independent home programs therefore have substantial influence over manufacturer adoption even when they do not manufacture the machines themselves.

Hospitals and Health Systems

Hospitals use compact dialysis systems for acute kidney injury, chronic dialysis patients admitted for other conditions, overflow treatment, critical-access needs, and decentralized dialysis delivery. Systems that minimize dependency on fixed water-treatment infrastructure can be especially attractive.

Hospital procurement differs from pure home dialysis purchasing because reliability, infection control, staff standardization, interoperability, emergency support, and enterprise contracting become more important.

Skilled Nursing and Post-Acute Facilities

Post-acute facilities represent an emerging end-user segment. Transporting medically complex residents to external dialysis clinics can create significant operational cost and patient burden. On-site dialysis programs supported by portable machines can reduce transportation and simplify care coordination.

The opportunity is strongest in facilities with sufficient dialysis volume to justify dedicated clinical partnerships.

Government, Veterans, and Rural Care Networks

Federal health systems, rural providers, community-based programs, and emergency-response organizations can benefit from portable dialysis where distance to conventional dialysis capacity is substantial. Portability also improves resilience during natural disasters or infrastructure disruptions.

By Technology Type

Bagged Dialysate Systems

Bagged dialysate systems provide maximum independence from fixed water infrastructure and remain highly relevant to genuinely portable treatment. Their major strengths are mobility, emergency preparedness, and treatment continuity.

The principal limitation is logistics. Dialysate is heavy and requires manufacturing, transportation, household storage, and waste handling. Providers therefore evaluate bagged systems partly as supply-chain platforms.

Integrated Water-Purification Systems

Integrated purification reduces dependence on externally prepared dialysate and can materially lower storage requirements. This architecture is attractive for high-frequency users and facilities where predictable water access is available.

Continued innovation will focus on water efficiency, treatment preparation time, maintenance requirements, disinfection, system reliability, and compatibility with residential plumbing.

Connected and Cloud-Enabled Systems

Connected systems are expected to record one of the strongest growth rates through 2035. They enable treatment-data transmission, remote clinical review, service diagnostics, software updates, adherence tracking, and potentially predictive maintenance.

Connectivity will become increasingly embedded in enterprise procurement because dialysis providers need centralized visibility across geographically distributed patient populations.

Software-Guided and User-Assisted Systems

User-guided technologies provide on-screen setup instructions, troubleshooting, workflow prompts, automated checks, and treatment documentation. These functions directly address the largest operational bottleneck in HHD: converting a highly technical clinical procedure into a process that trained non-professional users can perform reliably.

Software-supported usability is therefore expected to become one of the most important bases of competitive differentiation.

Regional Insights: Where the Market is Growing Fastest

The U.S. Portable Hemodialysis Machines Market is geographically segmented into the South, West, Northeast, and Midwest. Regional differences reflect dialysis population size, diabetes and hypertension burden, aging demographics, rurality, provider concentration, home dialysis infrastructure, availability of training centers, payer mix, and willingness of health systems to invest in decentralized care.

The South is estimated to represent the largest regional market in 2025 at approximately USD 0.22 billion, followed by the West and Northeast at approximately USD 0.13 billion each, and the Midwest at approximately USD 0.10 billion. By 2035, the South is forecast to reach roughly USD 0.72 billion, the West USD 0.50 billion, the Northeast USD 0.43 billion, and the Midwest approximately USD 0.34 billion.

South

The South is the largest U.S. portable hemodialysis machines market because it combines substantial population scale with elevated diabetes, hypertension, obesity, CKD, and ESKD burden. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia.

Texas represents one of the most commercially important state opportunities. Houston, Dallas-Fort Worth, San Antonio, and Austin support large nephrology and hospital networks, while significant rural geography makes decentralized dialysis clinically relevant. The state’s combination of high diabetes burden, population growth, and extensive provider networks creates opportunity across home HD, skilled nursing, and hospital applications.

Florida is particularly important because of its large older-adult population. CKD prevalence rises sharply after age 65, giving Florida a structurally large kidney-care population. Portable systems have potential across residential home dialysis, retirement communities, post-acute care networks, and high-volume metropolitan dialysis markets such as Miami, Tampa, Orlando, and Jacksonville.

Georgia and North Carolina are becoming more strategically important because of population growth and expanding integrated healthcare systems. Major academic and referral institutions create a pathway for evaluating newer home and portable technologies before adoption expands into community nephrology networks.

Virginia and Maryland have relatively sophisticated health-system infrastructure and strong penetration of value-oriented care models. Their urban and suburban populations make connected home dialysis attractive, while rural areas in both states retain meaningful access challenges.

Tennessee has a strong dialysis-provider presence and significant chronic disease burden. Nashville, Memphis, Knoxville, and Chattanooga provide commercial concentration, while surrounding rural areas support demand for decentralized kidney-care delivery.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia present a different opportunity profile. These states generally have substantial chronic disease burden but greater rurality and healthcare-access limitations. Portable dialysis can therefore deliver value where transportation to conventional facilities creates treatment friction.

The South is projected to increase from approximately USD 0.22 billion in 2025 to USD 0.72 billion by 2035, representing an estimated CAGR of approximately 12.6%. Large absolute patient volumes make the region the most important commercial territory for manufacturers even though percentage growth may be surpassed by the West.

West

The West is expected to record the fastest regional growth, expanding from approximately USD 0.13 billion in 2025 to USD 0.50 billion by 2035, equivalent to an estimated CAGR of approximately 14.4%.

The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest market in the West and one of the most influential markets nationally. It combines the country’s largest state population with advanced academic nephrology centers, integrated delivery networks, major managed-care organizations, digital-health adoption, and proximity to medtech innovation. California is also commercially relevant because Outset Medical is headquartered in the state and several dialysis-device developers have maintained West Coast operations.

Home size and housing type matter in California. Smaller urban residences in markets such as San Francisco and Los Angeles can favor compact machines with reduced storage requirements, while large suburban regions provide a strong environment for conventional HHD programs.

Arizona and Nevada are attractive growth markets because of population expansion and aging demographics. Phoenix, Tucson, Las Vegas, and Reno are developing larger specialty-care ecosystems while retaining significant geographic distances outside core metropolitan areas.

Washington and Oregon have strong integrated healthcare systems and comparatively mature adoption of digital care. Portable HD platforms that integrate remote treatment data, cloud-based clinical oversight, and patient-centered scheduling can align well with these delivery models.

Colorado and Utah combine population growth with sophisticated healthcare infrastructure and significant suburban expansion. Both states are attractive for home therapies because patients may travel considerable distances for specialty treatment.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets in absolute revenue but strategically important from an access perspective. Rural distance, weather disruption, island geography, and limited local dialysis capacity can make portable treatment particularly valuable. Alaska and Hawaii also receive special consideration under certain federal reimbursement adjustments because of their higher non-labor operating costs.

The West’s forecast leadership reflects technology adoption, population migration, connected-care infrastructure, and the strategic fit between portable dialysis and large geographic distances.

Northeast

The Northeast represented approximately USD 0.13 billion in 2025 and is projected to reach around USD 0.43 billion by 2035, representing an estimated CAGR of approximately 12.7%.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, Vermont, and Delaware, with Delaware sometimes operationally grouped with the South depending on the market framework.

New York is the region’s largest opportunity because of its population, dense provider base, and concentration of major academic institutions. Portable dialysis has different value propositions in New York City and upstate markets. In New York City, machine footprint, storage efficiency, and ease of installation are critical because residential space is limited. Upstate markets place greater emphasis on access and transportation.

Pennsylvania has a substantial dialysis population across Philadelphia, Pittsburgh, and regional health systems. Its combination of urban academic medicine and rural communities makes it an attractive mixed-setting market.

New Jersey offers high population density and strong proximity to major nephrology networks. Compact integrated dialysis systems are particularly relevant where hospital systems and home programs want to minimize installation complexity.

Massachusetts is strategically influential because of its kidney-care research ecosystem, medtech industry, and history of dialysis innovation. Fresenius Medical Care and NxStage maintain major operations in Massachusetts, giving the state direct importance within the competitive ecosystem.

Connecticut and Rhode Island have smaller populations but high healthcare utilization and well-developed health-system infrastructure. Maine, Vermont, and New Hampshire have smaller absolute dialysis volumes but greater rurality, making travel reduction an important component of portable dialysis value.

The Northeast will remain a high-value market because purchasers tend to evaluate technology through rigorous clinical, economic, and operational evidence. Successful vendors will require strong health-economic documentation rather than portability claims alone.

Midwest

The Midwest accounted for approximately USD 0.10 billion in 2025 and is expected to reach roughly USD 0.34 billion by 2035, representing an estimated CAGR of approximately 13.0%.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest Midwest opportunity, driven by the Chicago metropolitan healthcare market and an extensive network of community dialysis providers. Portable machines can support both urban home therapy and decentralized treatment across downstate communities.

Ohio has substantial chronic disease burden and several nationally recognized healthcare organizations. Cleveland, Columbus, and Cincinnati provide concentrated clinical markets, while rural Ohio creates opportunity for home-based and post-acute dialysis.

Michigan is a significant dialysis market because of population scale, diabetes burden, and established nephrology networks. Detroit and surrounding health systems provide large treatment volumes.

Minnesota has strategic importance beyond population size because of its longstanding medical-device ecosystem. The state is likely to remain influential in evaluation of new dialysis technologies, remote monitoring, and value-based kidney-care models.

Indiana, Wisconsin, and Missouri provide stable demand through established regional health systems, skilled nursing networks, and dialysis providers. Iowa, Kansas, Nebraska, North Dakota, and South Dakota have lower absolute volumes but stronger geographic-access challenges.

Portable dialysis is especially relevant across rural Midwestern areas where patients may travel substantial distances three times per week for conventional HD. Reducing transportation dependency can improve patient convenience while giving providers alternatives to establishing low-volume fixed dialysis facilities.

The Midwest is unlikely to overtake the South or West in absolute revenue, but its combination of chronic disease burden, rural access needs, and established integrated delivery networks makes it a durable expansion market.

Key Market Players

The U.S. Portable Hemodialysis Machines competitive landscape is unusual because the number of companies with established, FDA-cleared portable home hemodialysis platforms is substantially smaller than the wider dialysis-device ecosystem. The following organizations include direct machine competitors, dialysis-equipment manufacturers, emerging technology developers, and strategically important U.S. care-delivery organizations that influence machine adoption.

Fresenius Medical Care
NxStage Medical
Outset Medical
Quanta Dialysis Technologies
Diality
Vantive
B. Braun Medical
Nipro Medical Corporation
Nikkiso
Toray Medical
Asahi Kasei Medical
JMS North America
Mozarc Medical
Nextkidney
Physidia
EasyDial
DaVita
U.S. Renal Care
Dialysis Clinic, Inc.
Innovative Renal Care
Satellite Healthcare
Concerto Renal Services
Dialyze Direct

Fresenius Medical Care currently has the strongest position in dedicated portable HHD through the NxStage ecosystem. More than 15,300 U.S. patients were using NxStage HHD systems in 2025, and the platform benefits from an established training, consumables, technical support, connectivity, and provider infrastructure.

Outset Medical occupies a differentiated position with Tablo. Its strategy is based on reducing dialysis infrastructure through integrated water purification and establishing one platform across hospital, subacute, and home care. Outset generated approximately USD 119.5 million in total company revenue during 2025, including approximately USD 88.7 million of recurring consumables and service revenue, demonstrating the importance of recurring machine-linked economics.

Quanta represents one of the most important emerging competitors after receiving U.S. home-use clearance for SC+. Commercial success will depend on its ability to build provider training infrastructure, consumable distribution, field service, and clinical confidence comparable with established competitors.

Diality represents a potential future home-dialysis competitor. Its Moda-flx platform is cleared for professional environments and integrates reverse-osmosis water treatment. The company’s ongoing home-use clinical development could broaden future competition if the system receives an expanded indication.

Vantive, B. Braun, Nipro, Nikkiso, Toray, Asahi Kasei, JMS, and other established renal-device companies bring deep dialysis expertise but vary in their current U.S. positioning in genuinely portable HHD. Their manufacturing scale, fluid-management expertise, dialyzer portfolios, installed relationships, and service networks nevertheless make them strategically relevant.

Emerging developers such as Nextkidney, Physidia, and EasyDial illustrate the longer-term competitive threat from smaller, more portable, lower-water, or simplified dialysis architectures. Not all emerging systems are currently commercially available for U.S. home use, and regulatory status should therefore be evaluated separately for each platform.

Provider organizations are also strategically important. DaVita, U.S. Renal Care, Dialysis Clinic Inc., Innovative Renal Care, Satellite Healthcare, Concerto Renal Services, and Dialyze Direct can influence machine adoption because manufacturers require clinical training centers, patient-selection pathways, consumable logistics, and home-therapy programs to scale.

Over the forecast period, market share will increasingly depend on patient training success, home-therapy retention, machine uptime, cost per treatment, recurring consumable economics, clinician workflow, cybersecurity, remote monitoring, FDA approvals, and the capacity to support nationwide field service.

Recent Developments

Recent developments indicate that the U.S. portable hemodialysis market is entering a broader competitive phase.

Fresenius Medical Care continued expanding the NxStage installed base and reported more than 15,300 U.S. HHD patients using NxStage systems in 2025, compared with more than 14,500 in 2024. The rollout of VersiHD with GuideMe Software illustrates the industry’s shift toward software-guided patient training and simplified treatment workflows.

Quanta achieved an important regulatory milestone when the FDA cleared the SC+ Hemodialysis Device for home use in November 2024. This expanded the number of credible competitors capable of addressing the home hemodialysis market and is expected to intensify competition around usability, training, consumables, and provider economics.

Diality obtained FDA clearance for the Moda-flx Hemodialysis System and Cartridge in August 2024 for professional care applications. The company subsequently advanced clinical evaluation for a home-use indication. Moda-flx is strategically important because it combines flexible dialysis prescriptions with integrated reverse-osmosis water filtration.

Outset Medical continued commercializing Tablo across dialysis care settings and resolved the FDA warning-letter issues communicated to the company in February 2025. The episode reinforced the importance of regulatory compliance, promotional controls, quality systems, and post-market surveillance in dialysis-machine procurement.

Device safety remained a major industry consideration. In 2024, the FDA classified a corrective recall involving 879 U.S. Tablo systems as Class I in connection with potential exposure to certain toxic compounds associated with device components. Although the action involved correction rather than broad product removal, such events can influence value-analysis committees and increase attention to materials, water-path safety, quality management, and field remediation capability.

Reimbursement also evolved. Medicare expanded home dialysis payment pathways for qualifying acute kidney injury treatment beginning in 2025. This does not automatically create a large home-AKI market, but it removes one reimbursement barrier and increases the number of clinical scenarios in which providers can evaluate decentralized dialysis.

For 2026, CMS increased the ESRD PPS base rate to USD 281.71 per treatment while finalizing early termination of the ETC model. The policy environment is therefore shifting away from a single mandatory home-dialysis incentive toward broader provider responsibility for deciding where home dialysis creates clinical and economic value.

A further strategic development is the increasing emphasis on recurring revenue. Outset Medical generated the majority of its 2025 revenue from consumables and services rather than capital sales alone. Fresenius Medical Care similarly operates an ecosystem in which machine adoption drives recurring cartridges, dialysate, treatment supplies, connectivity, and support. Portable dialysis competition will therefore increasingly resemble a platform model rather than a one-time equipment market.

Conclusion

The U.S. Portable Hemodialysis Machines Market Size & Share is positioned to expand from approximately USD 0.58 billion in 2025 to USD 1.99 billion by 2035, representing a 13.10% CAGR during 2026–2035.

The growth thesis is supported by a large underlying kidney-failure population, continued expansion of home therapies, greater acceptance of self-care dialysis, improved machine usability, remote connectivity, decentralized care delivery, and growing competition among compact dialysis platforms.

However, the market should not be interpreted simply as a substitution of portable machines for conventional dialysis equipment. Portable HHD requires a different operating model. Successful commercialization depends on patient identification, training, vascular-access readiness, supply delivery, home assessment, technical support, remote clinical oversight, emergency planning, and program-level economics.

Fresenius Medical Care and NxStage retain a substantial first-mover advantage because of their established HHD installed base and supporting infrastructure. Outset Medical provides an alternative model built around integrated water purification and treatment across multiple care settings. Quanta’s entrance into U.S. home hemodialysis creates direct new competition, while Diality’s home-use clinical development could further expand vendor choice.

The most commercially attractive technologies through 2035 will be those that reduce training complexity, decrease infrastructure dependence, support treatment flexibility, improve connectivity, and demonstrate favorable total cost per treatment. Machine size alone will not determine market leadership.

The South will remain the largest regional opportunity because of population scale, chronic disease burden, and extensive dialysis demand. The West is expected to record the fastest growth because of connected-care adoption, demographic expansion, innovation infrastructure, and significant geographic distances. The Northeast will remain a premium evidence-driven market, while the Midwest will provide durable growth through integrated health systems and rural-access requirements.

For manufacturers, dialysis providers, healthcare investors, technology developers, component suppliers, and strategic buyers evaluating this market, the critical issue is no longer whether home dialysis technology will continue to improve. The more important questions are which platforms can meaningfully reduce the operational burden of home hemodialysis, how rapidly providers can scale training capacity, which machine architectures create the lowest sustainable treatment cost, and whether newer entrants can build service ecosystems capable of competing with established dialysis companies.

The companies that solve those operational questions—not simply the companies that build smaller machines—will define the U.S. portable hemodialysis market through 2035.

TABLE OF CONTENT

1. U.S. Portable Hemodialysis Machines Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Portable Hemodialysis Machine Manufacturers
1.6.2. Dialysis Cartridge, Fluid Management, and Component Suppliers
1.6.3. Dialysis Service Providers and Home Dialysis Networks
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Home Dialysis Training Centers and Nephrology Practices
1.6.6. Skilled Nursing and Post-Acute Care Providers
1.6.7. Distributors, Group Purchasing Organizations, and Specialty Suppliers
1.6.8. CMS, Commercial Payers, FDA, and Clinical Decision-Makers

What this section provides: This section defines the U.S. portable hemodialysis machines market boundary, inclusion and exclusion criteria, study methodology, assumptions, and stakeholder ecosystem so clients understand how market size, competitive positioning, and future demand are measured and validated.

2. U.S. Portable Hemodialysis Machines Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size & CAGR Snapshot, 2025–2035
2.8. High-Growth Opportunity Areas
2.9. Home Hemodialysis Adoption Opportunity
2.10. Competitive and Technology Outlook

What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical development, competitive intensity, home-dialysis penetration, leading technology platforms, and the highest-potential commercial opportunities through 2035.

3. U.S. Portable Hemodialysis Machines Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Chronic Kidney Disease and ESKD Burden
3.1.2. Growing Adoption of Home Hemodialysis
3.1.3. Increasing Patient Preference for Flexible and Decentralized Dialysis
3.1.4. Expansion of Compact and Low-Infrastructure Dialysis Platforms
3.1.5. Dialysis Nursing and Technician Workforce Constraints
3.1.6. Growth of Connected and Remote-Monitored Dialysis Care
3.1.7. Expansion of Dialysis into Post-Acute and Alternative Care Settings

3.2. Restraints and Their Impact Analysis
3.2.1. High Equipment and Recurring Consumable Costs
3.2.2. Patient Training and Caregiver Dependency
3.2.3. Home Infrastructure, Storage, Plumbing, and Water Requirements
3.2.4. Vascular Access and Patient Safety Concerns
3.2.5. Product Recall, Quality, and Reliability Risks
3.2.6. Uneven Home Hemodialysis Program Availability

3.3. Opportunities and Their Impact Analysis
3.3.1. Expansion of Home Hemodialysis Penetration
3.3.2. Portable Dialysis Adoption in Rural and Underserved Areas
3.3.3. Skilled Nursing Facility and Post-Acute Dialysis Expansion
3.3.4. Software-Guided Self-Dialysis and Automated Workflow
3.3.5. Lower-Water and Low-Dialysate Technologies
3.3.6. Remote Patient Monitoring and Cloud-Connected Dialysis
3.3.7. New Entrant Commercialization and Competitive Platform Expansion

3.4. Challenges and Their Impact Analysis
3.4.1. Patient Selection and Home Therapy Retention
3.4.2. Treatment Adherence and Training Attrition
3.4.3. Nationwide Technical Service Requirements
3.4.4. Consumable Supply and Last-Mile Logistics
3.4.5. Reimbursement and Provider Economics Uncertainty

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Home Hemodialysis Training Economics Analysis
3.8. Dialysis Provider Procurement Behavior Analysis
3.9. Total Cost per Treatment Analysis
3.10. Patient Mobility and Treatment Flexibility Analysis

What this section provides: This section explains the clinical, economic, reimbursement, technology, patient-behavior, and operational forces influencing portable hemodialysis adoption and helps clients assess growth opportunities against implementation and commercialization risks.

4. U.S. Portable Hemodialysis Machines Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitution
4.2.5. Competitive Rivalry

4.3. Portable Hemodialysis Machine Pricing Trend Analysis, 2025–2035
4.4. Treatment Consumables Pricing Analysis
4.5. Value Chain & Supply Chain Analysis
4.6. Dialysate, Cartridge, and Consumables Supply Chain Analysis
4.7. Impact of Digitalization and Connected Dialysis
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework Analysis
4.10. FDA 510(k), Home-Use Clearance, and Human Factors Requirements
4.11. CMS ESRD Prospective Payment System Analysis
4.12. Home and Self-Dialysis Training Reimbursement Landscape
4.13. Medicare and Commercial Payer Coverage Dynamics
4.14. Import/Export Restrictions & Tariff Impact
4.15. Government Kidney Care Initiatives
4.16. Impact of Escalating Geopolitical Tensions
4.17. Component and Semiconductor Supply Risk
4.18. Dialysis Provider Value Analysis and Procurement Decision Framework

What this section provides: This section gives clients a complete understanding of regulation, reimbursement, pricing, supply chains, digitalization, competitive forces, policy developments, and procurement economics affecting portable hemodialysis machine commercialization in the United States.

5. U.S. Portable Hemodialysis Machines Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Portable Home Hemodialysis Cyclers
5.1.3. Compact Integrated Hemodialysis Systems
5.1.4. Cartridge-Based Low-Infrastructure Hemodialysis Systems
5.1.5. Mobile Multi-Setting Hemodialysis Systems
5.1.6. Next-Generation and Emerging Portable Hemodialysis Platforms

What this section provides: This section identifies which portable hemodialysis machine categories are expected to generate the highest revenue, installed-base growth, recurring consumable demand, and technology adoption through 2035.

6. U.S. Portable Hemodialysis Machines Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Conventional Home Hemodialysis
6.1.3. Short Daily Home Hemodialysis
6.1.4. Nocturnal Home Hemodialysis
6.1.5. Acute and Transitional Hemodialysis
6.1.6. Post-Acute and Skilled Nursing Hemodialysis
6.1.7. Rural and Decentralized Hemodialysis

What this section provides: This section evaluates portable hemodialysis demand by treatment application and helps clients identify clinical settings with the strongest patient volumes, workflow advantages, reimbursement relevance, and long-term adoption potential.

7. U.S. Portable Hemodialysis Machines Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Home Dialysis Patients
7.1.3. Dialysis Providers and Home Dialysis Training Centers
7.1.4. Hospitals and Integrated Health Systems
7.1.5. Skilled Nursing Facilities and Post-Acute Care Centers
7.1.6. Nephrology Practices and Specialty Kidney Care Centers
7.1.7. Government, Veterans, Rural, and Community Care Networks

What this section provides: This section explains which patient groups, provider organizations, health systems, and alternative care environments are expected to drive portable dialysis machine placement, recurring utilization, and procurement activity through 2035.

8. U.S. Portable Hemodialysis Machines Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Bagged Dialysate Systems
8.1.3. Integrated Water-Purification Systems
8.1.4. Cartridge-Based Fluid Management Systems
8.1.5. Connected and Cloud-Enabled Hemodialysis Systems
8.1.6. Software-Guided and User-Assisted Systems
8.1.7. Low-Water, Sorbent, and Regenerative Dialysate Technologies

What this section provides: This section evaluates the technology architectures determining portability, water dependency, treatment setup, patient usability, remote clinical oversight, treatment economics, and future product differentiation.

9. U.S. Portable Hemodialysis Machines Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Manufacturer Procurement
9.1.3. Large Dialysis Provider Enterprise Contracts
9.1.4. Hospital and Integrated Delivery Network Contracts
9.1.5. Group Purchasing Organization Contracts
9.1.6. Distributor and Specialty Renal Supplier Sales
9.1.7. Home Dialysis Program and Managed Service Procurement

What this section provides: This section explains how portable hemodialysis systems and associated consumables are purchased in the United States, including manufacturer contracts, dialysis-provider standardization, IDN purchasing, GPO participation, distributor influence, and home-program procurement models.

10. U.S. Portable Hemodialysis Machines Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional ESKD and Hemodialysis Patient Population Analysis
10.1.4. Regional Home Hemodialysis Adoption Analysis
10.1.5. Regional Dialysis Provider and Training Infrastructure Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Rural Access and Decentralized Dialysis Opportunity

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Providers, and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Providers, and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Providers, and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Providers, and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and state-level analysis of all 50 U.S. states, allowing clients to identify home hemodialysis adoption hotspots, high-ESKD-demand territories, rural access opportunities, provider concentration, technology adoption patterns, and state-level commercial priorities.

11. U.S. Portable Hemodialysis Machines Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Installed Base and Competitive Penetration Analysis
11.3. Company Positioning Matrix
11.3.1. Market Leaders
11.3.2. Established Dialysis Technology Companies
11.3.3. Challengers
11.3.4. Innovators
11.3.5. Emerging Players
11.4. Product Benchmarking Matrix
11.4.1. Machine Portability and Footprint
11.4.2. Water and Dialysate Requirements
11.4.3. Home-Use Regulatory Status
11.4.4. Treatment Flexibility
11.4.5. Connectivity and Remote Monitoring
11.4.6. Consumables Model
11.4.7. Training and User Workflow

11.5. Company Profiles

11.5.1. Fresenius Medical Care
11.5.2. NxStage Medical
11.5.3. Outset Medical
11.5.4. Quanta Dialysis Technologies
11.5.5. Diality
11.5.6. Vantive
11.5.7. B. Braun Medical
11.5.8. Nipro Medical Corporation
11.5.9. Nikkiso Co., Ltd.
11.5.10. Toray Medical Co., Ltd.
11.5.11. Asahi Kasei Medical
11.5.12. JMS North America Corporation
11.5.13. Mozarc Medical
11.5.14. Nextkidney
11.5.15. Physidia
11.5.16. EasyDial
11.5.17. DaVita Inc.
11.5.18. U.S. Renal Care
11.5.19. Dialysis Clinic, Inc.
11.5.20. Innovative Renal Care
11.5.21. Satellite Healthcare
11.5.22. Dialyze Direct
11.5.23. Concerto Renal Services

Note: Manufacturer profiles will include company overview, portable hemodialysis portfolio, U.S. regulatory status, home-use positioning, installed base, consumables model, technology strategy, commercial partnerships, clinical development, competitive positioning, and recent developments. Dialysis-provider profiles will focus on home hemodialysis programs, portable-machine adoption, care-setting strategy, training infrastructure, and purchasing influence.

What this section provides: This section provides competitor benchmarking, market-share visibility, platform comparison, installed-base intelligence, home-use positioning, technology differentiation, provider influence, and strategic analysis of companies shaping the U.S. portable hemodialysis machines ecosystem.

12. U.S. Portable Hemodialysis Machines Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Ultra-Portable Hemodialysis Platforms
12.2.2. Low-Water Hemodialysis Technology
12.2.3. Sorbent-Based and Regenerative Dialysate Systems
12.2.4. Integrated Water Purification
12.2.5. Automated Cartridge and Fluid Management
12.2.6. AI-Assisted Troubleshooting and Treatment Support
12.2.7. Cloud-Connected Remote Hemodialysis Monitoring
12.2.8. Wearable and Ambulatory Artificial Kidney Technologies

12.3. Home Hemodialysis Penetration Outlook
12.4. Future Patient Training Model
12.5. Future Dialysis Provider Operating Model
12.6. Emerging Business Trends
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. M&A and Strategic Partnership Outlook
12.10. Commercialization Outlook for Emerging Portable Platforms

What this section provides: This section prepares clients for future technology shifts, changing home-hemodialysis penetration, emerging business models, new competitive entrants, investment priorities, and potential market-development scenarios through 2035.

13. U.S. Portable Hemodialysis Machines Market: Strategic Recommendations

13.1. Recommendations for Portable Hemodialysis Machine Manufacturers
13.2. Recommendations for Dialysis Providers
13.3. Recommendations for Hospitals and Health Systems
13.4. Recommendations for Home Dialysis Program Operators
13.5. Recommendations for Skilled Nursing and Post-Acute Providers
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors and Channel Partners
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. Patient Training and Adoption Strategy
13.11. Reimbursement and Market Access Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. State Prioritization and Commercial Territory Strategy
13.14. Partnership and Provider-Network Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, home-dialysis expansion, commercialization, market access, provider partnerships, geographic prioritization, investment decisions, and competitive differentiation.

14. U.S. Portable Hemodialysis Machines Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. Regulatory and Reimbursement Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope limitations, market-definition boundaries, forecasting assumptions, regulatory considerations, data-use conditions, and legal limitations.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Portable Hemodialysis Machines Market: Market Definition and Scope
TABLE 3: U.S. Portable Hemodialysis Machines Market: Research Methodology Framework
TABLE 4: U.S. Portable Hemodialysis Machines Market: Primary Research Framework
TABLE 5: U.S. Portable Hemodialysis Machines Market: Secondary Research Framework
TABLE 6: U.S. Portable Hemodialysis Machines Market: Key Assumptions
TABLE 7: U.S. Portable Hemodialysis Machines Market: Market Ecosystem Overview
TABLE 8: U.S. Portable Hemodialysis Machines Market: Stakeholder Analysis
TABLE 9: U.S. Portable Hemodialysis Machines Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Portable Hemodialysis Machines Market: Analyst Viewpoint Summary
TABLE 11: U.S. Portable Hemodialysis Machines Market: Market Attractiveness Index
TABLE 12: U.S. Portable Hemodialysis Machines Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Portable Hemodialysis Machines Market: Base Year Market Position, 2025
TABLE 14: U.S. Portable Hemodialysis Machines Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 15: U.S. Portable Hemodialysis Machines Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 16: U.S. Portable Hemodialysis Machines Market: CAGR Analysis, 2026–2035
TABLE 17: U.S. Portable Hemodialysis Machines Market: High-Growth Opportunity Areas
TABLE 18: U.S. Portable Hemodialysis Machines Market: Home Hemodialysis Adoption Opportunity
TABLE 19: U.S. Portable Hemodialysis Machines Market: Drivers; Impact Analysis
TABLE 20: U.S. Portable Hemodialysis Machines Market: Restraints; Impact Analysis
TABLE 21: U.S. Portable Hemodialysis Machines Market: Opportunities; Impact Analysis
TABLE 22: U.S. Portable Hemodialysis Machines Market: Challenges; Impact Analysis
TABLE 23: U.S. Portable Hemodialysis Machines Market: Patent & Innovation Analysis, 2021–2025
TABLE 24: U.S. Portable Hemodialysis Machines Market: Clinical Workflow Economics Matrix
TABLE 25: U.S. Portable Hemodialysis Machines Market: Home Hemodialysis Training Economics Matrix
TABLE 26: U.S. Portable Hemodialysis Machines Market: Dialysis Provider Procurement Behavior Matrix
TABLE 27: U.S. Portable Hemodialysis Machines Market: Patient Mobility and Treatment Flexibility Analysis
TABLE 28: U.S. Portable Hemodialysis Machines Market: Total Cost per Treatment Analysis
TABLE 29: U.S. Portable Hemodialysis Machines Market: PESTEL Analysis
TABLE 30: U.S. Portable Hemodialysis Machines Market: Porter’s Five Forces Analysis
TABLE 31: U.S. Portable Hemodialysis Machines Market: Pricing Trend Analysis, 2025–2035
TABLE 32: U.S. Portable Hemodialysis Machines Market: Machine Pricing Benchmark
TABLE 33: U.S. Portable Hemodialysis Machines Market: Consumables Pricing Analysis
TABLE 34: U.S. Portable Hemodialysis Machines Market: Value Chain Analysis
TABLE 35: U.S. Portable Hemodialysis Machines Market: Supply Chain Analysis
TABLE 36: U.S. Portable Hemodialysis Machines Market: Dialysate and Cartridge Supply Chain Analysis
TABLE 37: U.S. Portable Hemodialysis Machines Market: Digitalization and Connected Dialysis Impact
TABLE 38: U.S. Portable Hemodialysis Machines Market: Application & Innovation Landscape
TABLE 39: U.S. Portable Hemodialysis Machines Market: FDA Regulatory Framework Analysis
TABLE 40: U.S. Portable Hemodialysis Machines Market: FDA 510(k) and Home-Use Clearance Landscape
TABLE 41: U.S. Portable Hemodialysis Machines Market: Human Factors and Home-Use Requirements
TABLE 42: U.S. Portable Hemodialysis Machines Market: CMS ESRD PPS and Reimbursement Landscape
TABLE 43: U.S. Portable Hemodialysis Machines Market: Home and Self-Dialysis Training Reimbursement
TABLE 44: U.S. Portable Hemodialysis Machines Market: Medicare and Commercial Payer Coverage Dynamics
TABLE 45: U.S. Portable Hemodialysis Machines Market: Import/Export Restrictions & Tariff Impact
TABLE 46: U.S. Portable Hemodialysis Machines Market: Government Kidney Care Initiatives
TABLE 47: U.S. Portable Hemodialysis Machines Market: Geopolitical Risk Analysis
TABLE 48: U.S. Portable Hemodialysis Machines Market: Component and Supply Availability Risk
TABLE 49: U.S. Portable Hemodialysis Machines Market: Product Category Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Product Category
TABLE 51: U.S. Portable Hemodialysis Machines Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 52: U.S. Portable Hemodialysis Machines Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 53: Portable Home Hemodialysis Cyclers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Compact Integrated Hemodialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Cartridge-Based Low-Infrastructure Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Mobile Multi-Setting Hemodialysis Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Next-Generation and Emerging Portable Hemodialysis Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Portable Hemodialysis Machines Market: Application Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by Application
TABLE 60: U.S. Portable Hemodialysis Machines Market, by Application, 2021–2035 (US$ Billion)
TABLE 61: U.S. Portable Hemodialysis Machines Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 62: Conventional Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Short Daily Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Nocturnal Home Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Acute and Transitional Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Post-Acute and Skilled Nursing Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Rural and Decentralized Hemodialysis Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Portable Hemodialysis Machines Market: End User Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by End User
TABLE 70: U.S. Portable Hemodialysis Machines Market, by End User, 2021–2035 (US$ Billion)
TABLE 71: U.S. Portable Hemodialysis Machines Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 72: Home Dialysis Patients Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Dialysis Providers and Home Dialysis Training Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Skilled Nursing and Post-Acute Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Nephrology Practices and Specialty Kidney Care Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Government, Veterans, Rural and Community Care Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Portable Hemodialysis Machines Market: Technology Type Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 80: U.S. Portable Hemodialysis Machines Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 81: U.S. Portable Hemodialysis Machines Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 82: Bagged Dialysate Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: Integrated Water-Purification Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: Cartridge-Based Fluid Management Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: Connected and Cloud-Enabled Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Software-Guided and User-Assisted Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: Low-Water, Sorbent and Regenerative Dialysate Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Portable Hemodialysis Machines Market: Procurement Channel Snapshot, 2025
TABLE 89: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 90: U.S. Portable Hemodialysis Machines Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 91: U.S. Portable Hemodialysis Machines Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 92: Direct Manufacturer Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Large Dialysis Provider Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Hospital and Integrated Delivery Network Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Distributor and Specialty Renal Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Home Dialysis Program and Managed Service Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: U.S. Portable Hemodialysis Machines Market: Regional Snapshot, 2025
TABLE 99: Segment Dashboard; Definition and Scope, by Geography
TABLE 100: U.S. Portable Hemodialysis Machines Market, by Region, 2021–2035 (US$ Billion)
TABLE 101: U.S. Portable Hemodialysis Machines Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 102: U.S. Portable Hemodialysis Machines Market: Regional ESKD Patient Population Analysis
TABLE 103: U.S. Portable Hemodialysis Machines Market: Regional Home Hemodialysis Adoption Analysis
TABLE 104: U.S. Portable Hemodialysis Machines Market: Regional Dialysis Provider Infrastructure Analysis
TABLE 105: U.S. Portable Hemodialysis Machines Market: Regional Rural Access Opportunity Analysis
TABLE 106: West Region U.S. Portable Hemodialysis Machines Market: Regional Overview and Trends
TABLE 107: West Region U.S. Portable Hemodialysis Machines Market: Key Manufacturers, Providers and Procurement Ecosystem
TABLE 108: West Region U.S. Portable Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 109: West Region U.S. Portable Hemodialysis Machines Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 110: West Region U.S. Portable Hemodialysis Machines Market, by Application, 2021–2035 (US$ Billion)
TABLE 111: West Region U.S. Portable Hemodialysis Machines Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: West Region U.S. Portable Hemodialysis Machines Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 113: West Region U.S. Portable Hemodialysis Machines Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 114: California Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Washington Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Arizona Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Colorado Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Oregon Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Utah Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Nevada Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: New Mexico Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Idaho Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Montana Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Wyoming Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Alaska Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Hawaii Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Northeast Region U.S. Portable Hemodialysis Machines Market: Regional Overview and Trends
TABLE 128: Northeast Region U.S. Portable Hemodialysis Machines Market: Key Manufacturers, Providers and Procurement Ecosystem
TABLE 129: Northeast Region U.S. Portable Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 130: Northeast Region U.S. Portable Hemodialysis Machines Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Northeast Region U.S. Portable Hemodialysis Machines Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Northeast Region U.S. Portable Hemodialysis Machines Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Northeast Region U.S. Portable Hemodialysis Machines Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Northeast Region U.S. Portable Hemodialysis Machines Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: New York Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Massachusetts Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: New Jersey Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Pennsylvania Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Connecticut Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Maine Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Vermont Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: New Hampshire Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Rhode Island Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Delaware Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: South Region U.S. Portable Hemodialysis Machines Market: Regional Overview and Trends
TABLE 146: South Region U.S. Portable Hemodialysis Machines Market: Key Manufacturers, Providers and Procurement Ecosystem
TABLE 147: South Region U.S. Portable Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 148: South Region U.S. Portable Hemodialysis Machines Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 149: South Region U.S. Portable Hemodialysis Machines Market, by Application, 2021–2035 (US$ Billion)
TABLE 150: South Region U.S. Portable Hemodialysis Machines Market, by End User, 2021–2035 (US$ Billion)
TABLE 151: South Region U.S. Portable Hemodialysis Machines Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 152: South Region U.S. Portable Hemodialysis Machines Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Texas Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Florida Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Georgia Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: North Carolina Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Tennessee Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: South Carolina Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Alabama Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Mississippi Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Louisiana Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Arkansas Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Kentucky Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Oklahoma Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Virginia Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Maryland Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: West Virginia Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Midwest Region U.S. Portable Hemodialysis Machines Market: Regional Overview and Trends
TABLE 169: Midwest Region U.S. Portable Hemodialysis Machines Market: Key Manufacturers, Providers and Procurement Ecosystem
TABLE 170: Midwest Region U.S. Portable Hemodialysis Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 171: Midwest Region U.S. Portable Hemodialysis Machines Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 172: Midwest Region U.S. Portable Hemodialysis Machines Market, by Application, 2021–2035 (US$ Billion)
TABLE 173: Midwest Region U.S. Portable Hemodialysis Machines Market, by End User, 2021–2035 (US$ Billion)
TABLE 174: Midwest Region U.S. Portable Hemodialysis Machines Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 175: Midwest Region U.S. Portable Hemodialysis Machines Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 176: Illinois Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 177: Ohio Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 178: Michigan Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 179: Minnesota Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 180: Indiana Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 181: Wisconsin Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 182: Missouri Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 183: Iowa Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 184: Kansas Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 185: Nebraska Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 186: North Dakota Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 187: South Dakota Portable Hemodialysis Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 188: U.S. Portable Hemodialysis Machines Market: Competitive Landscape Snapshot, 2025
TABLE 189: U.S. Portable Hemodialysis Machines Market: Key Company Market Share Analysis, 2025
TABLE 190: U.S. Portable Hemodialysis Machines Market: Installed Base and Competitive Penetration Analysis
TABLE 191: U.S. Portable Hemodialysis Machines Market: Company Positioning Matrix
TABLE 192: U.S. Portable Hemodialysis Machines Market: Machine Portability and Footprint Benchmarking
TABLE 193: U.S. Portable Hemodialysis Machines Market: Water and Dialysate Requirement Benchmarking
TABLE 194: U.S. Portable Hemodialysis Machines Market: Home-Use Regulatory Status Benchmarking
TABLE 195: U.S. Portable Hemodialysis Machines Market: Connectivity and Remote Monitoring Benchmarking
TABLE 196: U.S. Portable Hemodialysis Machines Market: Consumables Model Benchmarking
TABLE 197: U.S. Portable Hemodialysis Machines Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 198: Fresenius Medical Care: Company Profile
TABLE 199: NxStage Medical: Company Profile
TABLE 200: Outset Medical: Company Profile
TABLE 201: Quanta Dialysis Technologies: Company Profile
TABLE 202: Diality: Company Profile
TABLE 203: Vantive: Company Profile
TABLE 204: B. Braun Medical: Company Profile
TABLE 205: Nipro Medical Corporation: Company Profile
TABLE 206: Nikkiso Co., Ltd.: Company Profile
TABLE 207: Toray Medical Co., Ltd.: Company Profile
TABLE 208: Asahi Kasei Medical: Company Profile
TABLE 209: JMS North America Corporation: Company Profile
TABLE 210: Mozarc Medical: Company Profile
TABLE 211: Nextkidney: Company Profile
TABLE 212: Physidia: Company Profile
TABLE 213: EasyDial: Company Profile
TABLE 214: DaVita Inc.: Company Profile
TABLE 215: U.S. Renal Care: Company Profile
TABLE 216: Dialysis Clinic, Inc.: Company Profile
TABLE 217: Innovative Renal Care: Company Profile
TABLE 218: Satellite Healthcare: Company Profile
TABLE 219: Dialyze Direct: Company Profile
TABLE 220: Concerto Renal Services: Company Profile
TABLE 221: U.S. Portable Hemodialysis Machines Market: Future Market Scenario Analysis, 2026–2035
TABLE 222: U.S. Portable Hemodialysis Machines Market: Optimistic, Realistic and Pessimistic Scenario Comparison
TABLE 223: U.S. Portable Hemodialysis Machines Market: Disruptive Technologies Impact Matrix
TABLE 224: U.S. Portable Hemodialysis Machines Market: Home Hemodialysis Penetration Outlook
TABLE 225: U.S. Portable Hemodialysis Machines Market: Future Patient Training Model
TABLE 226: U.S. Portable Hemodialysis Machines Market: Future Dialysis Provider Operating Model
TABLE 227: U.S. Portable Hemodialysis Machines Market: Emerging Business Trends
TABLE 228: U.S. Portable Hemodialysis Machines Market: Business Opportunities for Startups and Existing Players
TABLE 229: U.S. Portable Hemodialysis Machines Market: Investment Prioritization Matrix
TABLE 230: U.S. Portable Hemodialysis Machines Market: M&A and Strategic Partnership Outlook
TABLE 231: U.S. Portable Hemodialysis Machines Market: Commercialization Outlook for Emerging Portable Platforms
TABLE 232: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Manufacturers
TABLE 233: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Dialysis Providers
TABLE 234: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 235: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Home Dialysis Program Operators
TABLE 236: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Skilled Nursing and Post-Acute Providers
TABLE 237: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 238: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 239: U.S. Portable Hemodialysis Machines Market: Strategic Recommendations for New Entrants and Startups
TABLE 240: U.S. Portable Hemodialysis Machines Market: Go-to-Market Strategy Considerations
TABLE 241: U.S. Portable Hemodialysis Machines Market: Reimbursement and Market Access Strategy
TABLE 242: U.S. Portable Hemodialysis Machines Market: Product Positioning and Portfolio Expansion Guidance
TABLE 243: U.S. Portable Hemodialysis Machines Market: State Prioritization and Commercial Territory Strategy
TABLE 244: U.S. Portable Hemodialysis Machines Market: Provider Partnership Strategy
TABLE 245: U.S. Portable Hemodialysis Machines Market: Scope Limitation
TABLE 246: U.S. Portable Hemodialysis Machines Market: Market Definition Limitation
TABLE 247: U.S. Portable Hemodialysis Machines Market: Data Use Limitation
TABLE 248: U.S. Portable Hemodialysis Machines Market: Forecasting Limitation
TABLE 249: U.S. Portable Hemodialysis Machines Market: Regulatory and Reimbursement Limitation
TABLE 250: U.S. Portable Hemodialysis Machines Market: Legal Disclaimer
TABLE 251: U.S. Portable Hemodialysis Machines Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Portable Hemodialysis Machines Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Primary and Secondary Research Framework
FIGURE 4: U.S. Portable Hemodialysis Machines Market Ecosystem
FIGURE 5: Stakeholder Ecosystem
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: U.S. Portable Hemodialysis Machines Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 8: U.S. Portable Hemodialysis Machines Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 9: U.S. Portable Hemodialysis Machines Market Year-wise Growth Curve, 2021–2035
FIGURE 10: U.S. Portable Hemodialysis Machines Market CAGR Analysis, 2026–2035
FIGURE 11: U.S. Portable Hemodialysis Machines Market Dynamics
FIGURE 12: Market Drivers Impact Framework
FIGURE 13: Market Restraints and Challenges Framework
FIGURE 14: Innovation & Patent Landscape, 2021–2025
FIGURE 15: Clinical Workflow Economics Framework
FIGURE 16: Home Hemodialysis Training Economics Framework
FIGURE 17: Dialysis Provider Procurement Decision Framework
FIGURE 18: Patient Mobility and Treatment Flexibility Framework
FIGURE 19: Total Cost per Treatment Framework
FIGURE 20: PESTEL Analysis
FIGURE 21: Porter’s Five Forces Analysis
FIGURE 22: Value Chain Analysis
FIGURE 23: Supply Chain Analysis
FIGURE 24: Dialysate and Cartridge Supply Ecosystem
FIGURE 25: Connected and Remote-Monitored Dialysis Ecosystem
FIGURE 26: FDA Regulatory and Home-Use Clearance Framework
FIGURE 27: Human Factors and Home-Use Device Requirements Framework
FIGURE 28: CMS ESRD PPS and Home Dialysis Reimbursement Framework
FIGURE 29: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Portable Home Hemodialysis Cyclers Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 32: Compact Integrated Hemodialysis Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 33: Cartridge-Based Low-Infrastructure Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 34: Mobile and Emerging Portable Hemodialysis Platforms Growth Analysis, 2021–2035
FIGURE 35: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 36: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Conventional Home Hemodialysis Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: Short Daily Home Hemodialysis Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 39: Nocturnal Home Hemodialysis Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: Acute and Transitional Hemodialysis Opportunity Analysis
FIGURE 41: Post-Acute, Skilled Nursing and Rural Hemodialysis Opportunity Analysis
FIGURE 42: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 43: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Home Dialysis Patient Adoption Trend, 2021–2035
FIGURE 45: Dialysis Provider and Home Training Center Demand Outlook
FIGURE 46: Hospital and Integrated Health System Adoption Outlook
FIGURE 47: Skilled Nursing and Post-Acute Care Adoption Outlook
FIGURE 48: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 49: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Bagged Dialysate Systems Growth Analysis, 2021–2035
FIGURE 51: Integrated Water-Purification Systems Growth Analysis, 2021–2035
FIGURE 52: Cartridge-Based Fluid Management Technology Analysis
FIGURE 53: Connected and Cloud-Enabled Hemodialysis Growth Roadmap
FIGURE 54: Software-Guided and User-Assisted Dialysis Technology Roadmap
FIGURE 55: Low-Water, Sorbent and Regenerative Dialysate Technology Opportunity Map
FIGURE 56: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 57: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Direct Manufacturer and Dialysis Provider Procurement Framework
FIGURE 59: Hospital, IDN and GPO Procurement Framework
FIGURE 60: Distributor and Home Dialysis Managed Service Procurement Framework
FIGURE 61: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 62: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: U.S. ESKD Patient Population and Portable Hemodialysis Opportunity Map
FIGURE 64: U.S. Home Hemodialysis Adoption Opportunity Map
FIGURE 65: U.S. Dialysis Provider and Training Infrastructure Map
FIGURE 66: U.S. Rural and Underserved Dialysis Access Opportunity Map
FIGURE 67: West Region U.S. Portable Hemodialysis Machines Market Share Analysis, 2025
FIGURE 68: West Region Market Share Analysis by State, 2025
FIGURE 69: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: California Portable Hemodialysis Machines Market Size Forecast, 2021–2035
FIGURE 71: Washington and Oregon Portable Hemodialysis Market Opportunity Analysis
FIGURE 72: Arizona, Nevada, Colorado and Utah Growth Opportunity Analysis
FIGURE 73: Mountain and Pacific West Rural Dialysis Access Opportunity Map
FIGURE 74: Northeast Region U.S. Portable Hemodialysis Machines Market Share Analysis, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New York Portable Hemodialysis Machines Market Size Forecast, 2021–2035
FIGURE 78: Massachusetts Portable Hemodialysis Machines Market Opportunity Analysis
FIGURE 79: New Jersey and Pennsylvania Portable Hemodialysis Market Opportunity Analysis
FIGURE 80: New England Home Hemodialysis Adoption Outlook
FIGURE 81: South Region U.S. Portable Hemodialysis Machines Market Share Analysis, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Portable Hemodialysis Machines Market Size Forecast, 2021–2035
FIGURE 85: Florida Portable Hemodialysis Machines Market Size Forecast, 2021–2035
FIGURE 86: Georgia, North Carolina and Tennessee Market Opportunity Analysis
FIGURE 87: Southeast U.S. CKD and Home Dialysis Opportunity Map
FIGURE 88: South Region Rural and Underserved Dialysis Access Opportunity Map
FIGURE 89: Midwest Region U.S. Portable Hemodialysis Machines Market Share Analysis, 2025
FIGURE 90: Midwest Region Market Share Analysis by State, 2025
FIGURE 91: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Illinois Portable Hemodialysis Machines Market Size Forecast, 2021–2035
FIGURE 93: Ohio and Michigan Portable Hemodialysis Market Opportunity Analysis
FIGURE 94: Minnesota and Wisconsin Portable Hemodialysis Adoption Outlook
FIGURE 95: Midwest Rural Home Hemodialysis Access Opportunity Map
FIGURE 96: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 97: Installed Base and Competitive Penetration Analysis
FIGURE 98: Company Positioning Matrix
FIGURE 99: Key Player Product and Technology Portfolio Benchmarking
FIGURE 100: Portable Hemodialysis Machine Footprint Benchmarking
FIGURE 101: Water and Dialysate Requirement Benchmarking
FIGURE 102: Home-Use Regulatory Status Benchmarking
FIGURE 103: Connectivity and Remote Monitoring Benchmarking
FIGURE 104: Consumables and Recurring Revenue Model Benchmarking
FIGURE 105: Strategic Developments, Partnerships, Regulatory Clearances and Product Launches
FIGURE 106: Fresenius NxStage Competitive Positioning
FIGURE 107: Outset Tablo Competitive Positioning
FIGURE 108: Quanta SC+ Competitive Positioning
FIGURE 109: Diality Moda-flx Development and Commercialization Roadmap
FIGURE 110: U.S. Portable Hemodialysis Technology Innovation Roadmap
FIGURE 111: Home Hemodialysis Penetration Roadmap, 2026–2035
FIGURE 112: Future Patient Training and Self-Care Dialysis Model
FIGURE 113: Future Dialysis Provider Operating Model
FIGURE 114: Low-Water and Sorbent-Based Dialysis Technology Opportunity Map
FIGURE 115: AI-Assisted and Software-Guided Dialysis Development Roadmap
FIGURE 116: Future Market Scenario Analysis, 2026–2035
FIGURE 117: Optimistic, Realistic and Pessimistic Market Scenario Comparison
FIGURE 118: Disruptive Technologies Impact Matrix
FIGURE 119: Emerging Business Trends Matrix
FIGURE 120: Investment Prioritization Matrix
FIGURE 121: M&A and Strategic Partnership Opportunity Framework
FIGURE 122: Emerging Portable Platform Commercialization Roadmap
FIGURE 123: Strategic Growth Roadmap for U.S. Portable Hemodialysis Machine Companies
FIGURE 124: Dialysis Provider and Home Program Expansion Strategy Framework
FIGURE 125: Hospital and Post-Acute Market Development Framework
FIGURE 126: Go-to-Market Strategy Framework
FIGURE 127: Reimbursement and Market Access Strategy Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: U.S. State Prioritization and Commercial Territory Framework
FIGURE 130: Manufacturer–Provider Partnership Strategy Framework
FIGURE 131: Report Scope, Forecasting and Disclaimer Framework